IMP
Process View
acute phase response
An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "acute phase response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| IL1R1 | interleukin 1 receptor, type I | 0.920 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.830 | ||
| IL8 | interleukin 8 | 0.830 | ||
| IL1B | interleukin 1, beta | 0.724 | Human Mouse Rat | |
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.568 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.281 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.258 | ||
| TSC1 | tuberous sclerosis 1 | 0.252 | ||
| ALB | albumin | 0.203 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.193 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.182 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.180 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.163 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.108 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.097 | ||
| JUNB | jun B proto-oncogene | 0.092 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.076 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.070 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.070 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.065 | ||
| GAST | gastrin | 0.058 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.055 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.055 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.054 | Mouse Rat | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.051 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.049 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.047 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.047 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.045 | ||
| TF | transferrin | 0.042 | Rat | |
| STAT5A | signal transducer and activator of transcription 5A | 0.040 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.038 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.038 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.035 | ||
| B2M | beta-2-microglobulin | 0.030 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.025 | ||
| JAK1 | Janus kinase 1 | 0.024 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.023 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.019 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.019 | ||
| EGR1 | early growth response 1 | 0.018 | ||
| INSR | insulin receptor | 0.018 | ||
| ESR1 | estrogen receptor 1 | 0.016 | ||
| IER3 | immediate early response 3 | 0.016 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.015 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.014 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.014 | ||
| IL2RB | interleukin 2 receptor, beta | 0.013 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.011 | ||
| IRS2 | insulin receptor substrate 2 | 0.011 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.010 | ||
| ENO2 | enolase 2 (gamma, neuronal) | 0.010 | ||
| DCN | decorin | 0.010 |